(Q41150736)

27 September 2017

Loss of tumor-initiating cell activity in cyclophosphamide-treated breast xenografts (English)

1 reference

27 September 2017

1 reference

Steven P Zielske

1

1 reference

PMCID

2887643

27 September 2017

Aaron C Spalding

series ordinal

2

1 reference

PMCID

2887643

27 September 2017

Theodore S Lawrence

series ordinal

3

1 reference

27 September 2017

1 June 2010

1 reference

27 September 2017

Translational Oncology

1 reference

27 September 2017

3

1 reference

27 September 2017

3

1 reference

27 September 2017

149-152

1 reference

Selective enrichment of hepatocellular cancer stem cells by chemotherapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Cancer stem cells and chemoradiation resistance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Temozolomide preferentially depletes cancer stem cells in glioblastoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Stem cells in mammary development and carcinogenesis: implications for prevention and treatment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Prospective identification of tumorigenic breast cancer cells

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2887643

14 June 2018

Identifiers

DOI

10.1593/TLO.09307

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

PMCID

2887643